Post-transplant Hyperuricemia as a Cardiovascular Risk Factor

被引:5
|
作者
Uyar, M. Erkmen [1 ]
Sezer, S. [1 ]
Bal, Z. [1 ]
Guliyev, O. [1 ]
Tutal, E. [1 ]
Kulah, E. [1 ]
Genctoy, G. [1 ]
Acar, N. Ozdemir [1 ]
Haberal, M. [2 ]
机构
[1] Baskent Univ, Dept Nephrol, Antalya, Turkey
[2] Baskent Univ, Dept Gen Surg, TR-06490 Ankara, Turkey
关键词
SERUM URIC-ACID; KIDNEY-TRANSPLANT RECIPIENTS; RENAL-DISEASE; GRAFT DYSFUNCTION; PATHOGENETIC ROLE; HYPERTENSION; ASSOCIATION; SURVIVAL; GOUT;
D O I
10.1016/j.transproceed.2015.03.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose. Uric acid is known to impair endothelial cell function and to stimulate the development of renal interstitial fibrosis. The aim of this study was to evaluate the association between first-year hyperuricemia with graft dysfunction and the development of cardiovascular risk disorders in renal transplant recipients. Methods. One hundred kidney transplant recipients (31 female, 45.9 +/- 9.6 post-transplantation months) with normal graft functions were enrolled. The clinical biochemical parameters in the first post-transplantation year were retrospectively recorded and searched for the predictive value in yearly determined graft function and association with cross-sectionally analyzed cardiovascular parameters, including body composition analyses, ambulatory blood pressure monitoring data, and pulse wave velocity. Hyperuricemia was defined as an uric acid level of >= 6.5 mg/dL that persisted for at least 2 consecutive tests. Results. One year after transplantation, 37% of subjects had hyperuricemia. According to cross-sectional data, sagittal abdominal diameter (P = .002) and hip circumferences (P = .013) were significantly higher in hyperuricemic patients than in normouricemic ones. Hyperuricemic patients had higher fat (P = .014) and muscle mass (P = .016) than normouremic patients. Hyperuricemic patients had significantly higher mean systolic BP (P = .044) than normouremic patients. Hyperuricemic patients had significantly higher pulse wave velocity levels (P = .0001) and left ventricular mass index (P = .044) than normouremic patients. The yearly decline in estimated glomerular filtration rate levels was significantly higher in hyperuricemic patients (P = .0001) than in normouricemic ones. Conclusion. Post-transplantation hyperuricemia is associated with hypertension, arterial stiffness, and dyslipidemia; it should be accepted not only as a marker for renal allograft dysfunction but also as a cardiovascular risk factor in renal transplant recipients.
引用
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [1] Post-transplant hyperglycemia, an underestimated cardiovascular risk factor in kidney transplant recipients
    Cosio, FG
    Kudva, Y
    Textor, SC
    Griffin, MD
    Larson, TS
    Stegall, MD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 410 - 410
  • [2] HYPERURICEMIA AS A CARDIOVASCULAR RISK FACTOR in RENAL TRANSPLANT RECIPIENTS
    Uyar, Mehtap Erkmen
    Sezer, Siren
    Bal, Zeynep
    Guliyev, Orhan
    Colak, Turan
    Demirci, Bahar Gurlek
    Acar, Nurhan Ozdemir
    Haberal, Mehmet
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 557 - 557
  • [3] POST-TRANSPLANT DIABETES MELLITUS AS RISK FACTOR
    Idrizi, Alma
    Barbullushi, Myftar
    Thereska, Nestor
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 268 - 268
  • [5] Hyperuricemia as a Cardiovascular Risk Factor in Renal Transplant Recipients.
    Uyar, M. Erkmen
    Sezer, S.
    Bal, Z.
    Guliyev, O.
    Colak, T.
    Demirci, B. Gurlek
    Haberal, M.
    [J]. TRANSPLANTATION, 2014, 98 : 521 - 521
  • [6] Hyperuricemia as a Cardiovascular Risk Factor in Renal Transplant Recipients.
    Uyar, M. Erkmen
    Sezer, S.
    Bal, Z.
    Guliyev, O.
    Colak, T.
    Demirci, B. Gurlek
    Haberal, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 521 - 521
  • [7] Post-Transplant Cardiovascular Disease
    Birdwell, Kelly A.
    Park, Meyeon
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (12): : 1878 - 1889
  • [8] Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?
    Congly, Stephen E.
    [J]. ANNALS OF HEPATOLOGY, 2022, 27 (03)
  • [9] Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?
    Maestro de la Calle, Guillermo
    Fernandez-Ruiz, Mario
    Lopez-Medrano, Francisco
    Polanco, Natalia
    Gonzalez, Esther
    San Juan, Rafael
    Ruiz-Merlo, Tamara
    Origuen, Julia
    Paz-Artal, Estela
    Andres, Amado
    Maria Aguado, Jose
    [J]. ATHEROSCLEROSIS, 2018, 269 : 204 - 210
  • [10] CORONARY ARTERY CALCIFICATIONS IN LIVER TRANSPLANT RECIPIENTS AND RISK OF POST-TRANSPLANT CARDIOVASCULAR EVENTS
    Pagano, Giulia
    Escude, Laia
    Ruiz, Pablo
    Colmenero, Jordi
    Crespo, Gonzalo
    [J]. HEPATOLOGY, 2022, 76 : S498 - S499